PARIS, FRANCE / ACCESS Newswire / October 16, 2025 / Owkin today announces the launch of K Pro, its co-pilot bringing advanced agentic AI to biomedical research and drug development. K Pro helps ...
Built on a decade of Owkin’s AI innovation and in close collaboration with leading academic and industry partners, K Pro is a scientist-first co-pilot, accessible to both researchers and executives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback